2006
DOI: 10.1523/jneurosci.4946-05.2006
|View full text |Cite
|
Sign up to set email alerts
|

The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments

Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and neuropathological changes, including the deposition of amyloid ␤ (A␤) in senile plaques. The mechanisms causing the disease and A␤ accumulation are not well understood, but important genetic associations with apolipoprotein E genotype and involvement of lipoprotein receptors have become apparent. LR11 (also known as SorLA), a member of the low-density lipoprotein receptor family, has been identified prev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

13
231
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 257 publications
(250 citation statements)
references
References 52 publications
13
231
1
Order By: Relevance
“…The observation of an alternative pathway for APP exit from the TGN also raises the possibility that some fraction of APP is always routed via the endosomal/lysosomal route (also see Ang et al, 2004 and related studies) and that it is the abundance and relative affinities of different binding partners that determines the percentage of APP that traffics between the different alternative paths, which in turn could have an important impact on processing and A␤ generation. For example, LR11/SorLa is a lipoprotein receptor with links to Alzheimer's disease (Andersen et al, 2005;Offe et al, 2006;Rogaeva et al, 2007) that binds directly to APP in their lumenal domains (Andersen et al, 2006). The cytosolic tail of LR11 binds to GGAs (Jacobsen et al, 2002) and is thus predicted to exit the TGN via endosomal/lysosomal routing and could provide the means for recruitment of APP into GGA carriers and direct traffic into the endosomal system.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The observation of an alternative pathway for APP exit from the TGN also raises the possibility that some fraction of APP is always routed via the endosomal/lysosomal route (also see Ang et al, 2004 and related studies) and that it is the abundance and relative affinities of different binding partners that determines the percentage of APP that traffics between the different alternative paths, which in turn could have an important impact on processing and A␤ generation. For example, LR11/SorLa is a lipoprotein receptor with links to Alzheimer's disease (Andersen et al, 2005;Offe et al, 2006;Rogaeva et al, 2007) that binds directly to APP in their lumenal domains (Andersen et al, 2006). The cytosolic tail of LR11 binds to GGAs (Jacobsen et al, 2002) and is thus predicted to exit the TGN via endosomal/lysosomal routing and could provide the means for recruitment of APP into GGA carriers and direct traffic into the endosomal system.…”
Section: Discussionmentioning
confidence: 99%
“…Overexpression of human Mints was achieved in HEK293 cells by transient transfection using the pBK vector, which drives expression off the cytomegalovirus promoter, and A␤ 1-40 levels were determined in conditioned media as described previously (Offe et al, 2006). Empty vector was used as a control.…”
Section: Determination Of Secreted A␤ Levelsmentioning
confidence: 99%
“…Sortilin-related receptor 1 (also known as sorLA and LR11) is an excellent biological candidate gene due to its role in amyloid precursor protein (APP) processing and evidence that variation in SORL1 levels are associated with both APP [1,15] and LOAD [19]. Association between variation in SORL1 and LOAD has been reported in Northern Europeans, Caucasian Americans, Caribbean Hispanics and Israeli Arabs [18]; Caribbean Hispanics and Caucasian Americans [6]; Han Chinese [23]; and Caucasian Americans with Down syndrome [7].…”
mentioning
confidence: 99%
“…According to current concepts, SORLA inhibits trafficking of APP into cellular compartments where secretases reside, thereby reducing the extent of proteolytic breakdown of this precursor into neurotoxic amyloid-β peptides. Based on cumulative evidence from studies in cultured cells [5,8,9] in animal models [2,10] and in humans [6], SORLA is now considered a major risk factor for the sporadic form of AD (reviewed in [11]). …”
Section: Introductionmentioning
confidence: 99%